Generation bio to present at american society of gene & cell therapy 2021 virtual annual meeting

Cambridge, mass., april 27, 2021 (globe newswire) -- generation bio co. (nasdaq: gbio), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced three digital presentations at the american society of gene & cell therapy (asgct) 2021 virtual annual meeting taking place may 11-14. the presentations will cover data supporting use of the company's platform for antibody gene therapy, a summary of previously released preclinical data from the hemophilia a program and insight into cedna construct engineering for factor viii.
GBIO Ratings Summary
GBIO Quant Ranking